Event Brief
Feb 6, 2026 at 5:04 AM ET
Fosun Pharma’s US$1.55B Eisai Deal Signals Shift
By The BriefBrief
Fosun Pharma licenses cancer drug to Eisai for US$1.55B, marking a trend in long-term partnerships in drug development.
WHO: Fosun Pharma, Eisai
WHAT: Licensing agreement for cancer drug
WHEN: Feb 6, 2026 at 4:00 AM ET
WHERE: China, Japan
WHY: To establish long-term collaborations in drug development
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
